Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities

NCT01431105 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Kawasaki Disease

Interventions

DRUG: Atorvastatin

Sponsor

University of California, San Diego

Collaborators

[object Object]
[object Object]